← Leaderboards
Warren Wu
New York University School Of Medicine
$153,308
Attributed
$153,308
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $51.8K · FY2020–22$100K$75K$50K$25K$0
'20
'21
'22
Funding mix
By agency
NIH$153,308 · 1
By mechanism
F30$153,308 · 1
Top collaborators
No co-investigators on record.
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Kwok Kin Wong$31,472,345
- Thales Papagiannakopoulos$8,767,709
- William N Rom$26,662,104
- Leopoldo Nicolas Segal$9,785,416
- Eva Hernando$15,270,218
Others in their field
Other Emerging Leaders on “Anemia”
- Dawn C Ward · University Of California Los Angeles$7,282,377
- Angelo D'alessandro · University Of Colorado Denver$6,941,382
- Geoffrey Roger Hill · Fred Hutchinson Cancer Center$6,865,597
- Wei Du · West Virginia University$6,639,629
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,507,943
- Robert A.j. Signer · University Of California, San Diego$6,248,697
Research focus
AnemiaAntioxidantsBaseBilirubinBiochemicalCancer CellCancer GeneticsCancer TherapyCarbon MonoxideCatabolismCellsCessation Of LifeChronicComplexDependenceDesignDisease ProgressionDriver MutationEfficacy TestingElectron TransportEnzymesEventFellowshipAdult
Grant awards (3)
Targeting Heme Metabolism for the Treatment of KRAS- KEAP1-Mutant Lung Adenocarcinoma$51,752
F30 · FY2022 · CA · contact PI
Targeting Heme Metabolism for the Treatment of KRAS- KEAP1-Mutant Lung Adenocarcinoma$51,036
F30 · FY2021 · CA · contact PI
Targeting Heme Metabolism for the Treatment of KRAS- KEAP1-Mutant Lung Adenocarcinoma$50,520
F30 · FY2020 · CA · contact PI